An intervention study to prevent sarcopenia in hospitalized patients
Not Applicable
Recruiting
- Conditions
- Type2 diabetes
- Registration Number
- JPRN-jRCTs051190108
- Lead Sponsor
- Ikeda Kaori
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients with type2 diabetes
Exclusion Criteria
Patients with type1 diabetes
Steroid-treated patients
Patients who received gastrectomy, pancreatectomy, or intestinal resection
Patients who is difficult to be assessed muscle strength because of neuromuscular disease
Somatostatin analog-treated patients
Patients with hypothalamus or pituitary disease
Patients who restrict protein intake because of kidney disease
Patients who have difficulty of food intake or ingestion
Patients with dementia
Patients who restrict exercise
Patients whose ADL (Activity of Daily Living) is weakened
Unsuitable patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decline of muscle mass during hospitalization
- Secondary Outcome Measures
Name Time Method Body composition, physical performance, chewing ability, attentional control, anabolic hormones for muscle growth, the change of blood glucose and glucose metabolic hormone, the change of amino acids fractionation, the change of lactate